    <SEC-DOCUMENT>0001193125-26-126237-index.html : 20260326
    <SEC-HEADER>0001193125-26-126237.hdr.sgml : 20260326
    <ACCEPTANCE-DATETIME>20260326160928
    ACCESSION NUMBER:		0001193125-26-126237
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20251231
    FILED AS OF DATE:		20260326
    DATE AS OF CHANGE:		20260326
    EFFECTIVENESS DATE:		20260326

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			IN8BIO, INC.
    		CENTRAL INDEX KEY:			0001740279
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				825462585
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-39692
    		FILM NUMBER:		26798256

    	BUSINESS ADDRESS:
    		STREET 1:		EMPIRE STATE BUILDING
    		STREET 2:		350 5TH AVENUE, SUITE 5330
    		CITY:			NEW YORK
    		STATE:			NY
    		ZIP:			10118
    		BUSINESS PHONE:		(646) 600-6438

    	MAIL ADDRESS:
    		STREET 1:		EMPIRE STATE BUILDING
    		STREET 2:		350 5TH AVENUE, SUITE 5330
    		CITY:			NEW YORK
    		STATE:			NY
    		ZIP:			10118

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Incysus Therapeutics, Inc.
    		DATE OF NAME CHANGE:	20180510
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>d116358dars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: d116358dars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>